Nkarta, Inc. (NKTX)
2.26
+0.04
(+1.80%)
USD |
NASDAQ |
Oct 09, 16:00
2.26
0.00 (0.00%)
After-Hours: 19:21
Nkarta Market Cap : 161.87M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 159.00M |
| October 07, 2026 | 162.58M |
| October 06, 2026 | 165.45M |
| October 05, 2026 | 181.20M |
| October 02, 2026 | 184.43M |
| October 01, 2026 | 183.35M |
| September 30, 2026 | 187.65M |
| September 29, 2026 | 187.65M |
| September 28, 2026 | 191.23M |
| September 25, 2026 | 196.96M |
| September 24, 2026 | 204.12M |
| September 23, 2026 | 197.68M |
| September 22, 2026 | 211.29M |
| September 21, 2026 | 206.27M |
| September 18, 2026 | 202.69M |
| September 17, 2026 | 201.26M |
| September 16, 2026 | 205.56M |
| September 15, 2026 | 206.27M |
| September 14, 2026 | 209.14M |
| September 11, 2026 | 208.42M |
| September 10, 2026 | 201.26M |
| September 09, 2026 | 208.42M |
| September 08, 2026 | 231.34M |
| September 04, 2026 | 209.14M |
| September 03, 2026 | 199.83M |
| Date | Value |
|---|---|
| September 02, 2026 | 198.04M |
| September 01, 2026 | 193.38M |
| August 31, 2026 | 194.10M |
| August 28, 2026 | 197.68M |
| August 27, 2026 | 196.96M |
| August 26, 2026 | 188.37M |
| August 25, 2026 | 194.10M |
| August 24, 2026 | 185.50M |
| August 21, 2026 | 190.52M |
| August 20, 2026 | 176.91M |
| August 19, 2026 | 181.92M |
| August 18, 2026 | 172.61M |
| August 17, 2026 | 174.04M |
| August 14, 2026 | 166.88M |
| August 13, 2026 | 164.73M |
| August 12, 2026 | 171.18M |
| August 11, 2026 | 166.88M |
| August 10, 2026 | 176.19M |
| August 07, 2026 | 172.61M |
| August 06, 2026 | 164.01M |
| August 05, 2026 | 156.84M |
| August 04, 2026 | 161.12M |
| August 03, 2026 | 153.27M |
| July 31, 2026 | 149.00M |
| July 30, 2026 | 153.27M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.405B |
| Alnylam Pharmaceuticals, Inc. | 31.10B |
| Savara, Inc. | 1.012B |
| Vericel Corp. | 2.051B |
| Biogen, Inc. | 33.35B |
Market Cap Related Metrics
| PEG Ratio | -0.2133 |
| Price to Book Value | 0.6534 |
| Price | 2.26 |
| Earnings Yield | -69.92% |
| PEGY Ratio | -0.2133 |